# Monocacy Therapeutics Inc. — Form D

Monocacy Therapeutics Inc. of MONROVIA, MD, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-27. $114K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-05-27
- Form: D
- Accession: 0002137361-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $114K
- Minimum investment: $10K
- Investors: 2
- Revenue range: Decline to Disclose
- SEC file number: 021-585336

## Issuer

- Name: Monocacy Therapeutics Inc.
- CIK: 0002137361
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4716 MONROVIA BLVD, MONROVIA, MD, 21770
- Phone: 3019790911

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Suman Vodnala | Related Person | Alameda, CA |

## More

- [CIK 2137361 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2137361&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002137361-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.